AJP-Heart and Circulatory Physiology Podcast

Astronaut Arterial Stiffness and Insulin Resistance

Is exercise really the best medicine…in space? In this fascinating podcast, Consulting Editor David Gutterman (Medical College of Wisconsin) interviews lead author Richard Hughson (University of Waterloo) and content expert Walter Wray (University of Utah) about the latest work by Hughson and co-authors on how zero gravity alters vascular stiffness and insulin resistance, particularly in vessels in the head and neck. This latest work from Hughson and colleagues has important implications for long-term spaceflight, like missions to Mars and space station inhabitation. In addition, comparisons to bed rest studies make the case that acute changes in vascular stiffness may be treated with exercise, but how much is enough? With the recent completion of NASA astronaut Scott Kelly’s year in space, this podcast is not only timely, it is literally “out of this world.” Listen now.

Richard L. Hughson, Andrew D. Robertson, Philippe Arbeille, J. Kevin Shoemaker, James W. E. Rush, Katelyn S. Fraser, Danielle K. Greaves Increased postflight carotid artery stiffness and inflight insulin resistance resulting from 6-mo spaceflight in male and female astronauts Am J Physiol Heart Circ Physiol, published March 1, 2016. DOI: 10.1152/ajpheart.00802.2015.

Gender Differences in Acute Decompensated Heart Failure

Do we need to better understand gender differences in order to understand the pathophysiology of heart failure? Yes, according to a new study by Nakada et al. In the English version of this dual language podcast, listen as Associate Editor Masafumi Kitakaze interviews lead author Yoshihiko Saito (Nara Medical University) and guest expert Tomoko Ichiki (Mayo Clinic) about the work by Saito and colleagues, which analyzed the differences in prognostic power of plasma B-type natriuretic peptide (BNP) levels in men and women, as well as gender differences in age and ejection fraction distribution among heart failure patients. How do the results of Saito and colleagues, which clearly show that the pathophysiology of heart failure differs between men and women, impact potential clinical treatment strategies? Listen and learn more.

Yasuki Nakada, Rika Kawakami, Tomoya Nakano, Akihiro Takitsume, Hitoshi Nakagawa, Tomoya Ueda, Taku Nishida, Kenji Onoue, Tsunenari Soeda, Satoshi Okayama, Yukiji Takeda, Makoto Watanabe, Hiroyuki Kawata, Hiroyuki Okura, Yoshihiko Saito Gender Differences in Clinical Characteristics and Long-Term Outcome in Acute Decompensated Heart Failure Patients with Preserved and Reduced Ejection Fraction Am J Physiol Heart Circ Physiol, published online January 8, 2016, DOI: 10.1152/ajpheart.00602.2015.

JAPANESE LANGUAGE PODCAST: Gender Differences in Acute Decompensated Heart Failure

Do we need to better understand gender differences in order to understand the pathophysiology of heart failure? Yes, according to a new study by Nakada et al. In the Japanese version of this dual language podcast, listen as Associate Editor Masafumi Kitakaze interviews lead author Yoshihiko Saito (Nara Medical University) and guest expert Tomoko Ichiki (Mayo Clinic) about the work by Saito and colleagues, which analyzed the differences in prognostic power of plasma B-type natriuretic peptide (BNP) levels in men and women, as well as gender differences in age and ejection fraction distribution among heart failure patients. How do the results of Saito and colleagues, which clearly show that the pathophysiology of heart failure differs between men and women, impact potential clinical treatment strategies? Listen and learn more.

Yasuki Nakada, Rika Kawakami, Tomoya Nakano, Akihiro Takitsume, Hitoshi Nakagawa, Tomoya Ueda, Taku Nishida, Kenji Onoue, Tsunenari Soeda, Satoshi Okayama, Yukiji Takeda, Makoto Watanabe, Hiroyuki Kawata, Hiroyuki Okura, Yoshihiko Saito Gender Differences in Clinical Characteristics and Long-Term Outcome in Acute Decompensated Heart Failure Patients with Preserved and Reduced Ejection Fraction Am J Physiol Heart Circ Physiol, published online January 8, 2016, DOI: 10.1152/ajpheart.00602.2015.

Sitting and Endothelial Dysfunction

Is a stand-desk healthier for your arteries? Listen to this intriguing new podcast about endothelial dysfunction due to a reduction in blood flow and shear stress following prolonged periods of sitting. Associate Editor Nancy Kanagy (University of New Mexico School of Medicine) interviews lead author Jaume Padilla (University of Missouri) and guest expert Lee Stoner (Massey University, Wellington, New Zealand) about the work by Restaino et al, which utilized local heating to alleviate the normal reduction in shear stress that occurs with prolonged sitting in healthy male subjects. Did the heating protocol prevent post-sitting decreases in endothelium dilation? What do Padilla and colleagues speculate is the primary mechanistic pathway by which reduction in blood flow in shear stress results in an impairment in endothelium-dilation? What are the public health ripple effects here, in particular for spinal cord injury patients and people suffering from peripheral artery disease? We tackle these questions and more. Listen now.

Robert M. Restaino, Lauren K. Walsh, Takuma Morishima, Jennifer R. Vranish, Luis A. Martinez-Lemus, Paul J. Fadel, Jaume Padilla Endothelial dysfunction following prolonged sitting is mediated by a reduction in shear stress Am J Physiol Heart Circ Physiol, published March 1, 2016, DOI: 10.1152/ajpheart.00943.2015.

Development of a NRF2 Knockout Rat

How can we develop a deeper understanding of the regulation and activation of NRF2 in order to target therapies that depend on the inhibition of oxidative stress in a variety of disease states? Our latest podcast seeks an answer to this and more. Listen as Editor in Chief Irving H. Zucker (University of Nebraska Medical Center) interviews lead author Julian Lombard (Medical College of Wisconsin) and content expert Junie Paula Warrington (University of Mississippi Medical Center) about the innovative work by Priestley et al. Lombard and colleagues developed a NRF2 knockout rat to investigate the role of NRF2 in microvascular regulation in the context of a high-salt diet. What are the implications for the pathogenesis of hypertension? And how to “just right” levels of angiotensin 2 play a part in maintaining the NRF2 vs. oxidant stress balance? Listen and find out.

Jessica R. C. Priestley, Katie E. Kautenburg, Marc C. Casati, Bradley T. Endres, Aron M. Geurts, Julian H. Lombard The NRF2 knockout rat: a new animal model to study endothelial dysfunction, oxidant stress, and microvascular rarefaction Am J Physiol Heart Circ Physiol, published February 15, 2016. DOI: 10.1152/ajpheart.00586.2015.

BRS-3 Regulation of Blood Pressure and Heart Rate

Just what are the contributions of bombesin-like receptor 3 to blood pressure regulation? Listen as Associate Editor Debra I. Diz (Wake Forest University School of Medicine) interviews lead author Marc Reitman (National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health) and content expert Amy C. Arnold (Vanderbilt University) about the work by Lateef et al., which combined the use of genetic tools—a BRS-3 knockout mouse—as well as pharmacologic tools to explore the effect of this orphan receptor on blood pressure, filling a void in the literature about the physiology of BRS-3. This podcast tackles just about everything: “uncooperative” mice, effects on baroreflex sensitivity, and the controversial subject of pharmacological interventions for the treatment of obesity. Does the absence of evidence equate to “the evidence of absence”? Listen and find out.

Dalya M. Lateef, Cuiying Xiao, Robert J. Brychta, André Diedrich, Jurgen Schnermann, Marc L. Reitman Bombesin-Like Receptor 3 Regulates Blood Pressure and Heart Rate via a Central Sympathetic Mechanism Am J Physiol Heart Circ Physiol, published online January 22, 2016, DOI: 10.1152/ajpheart.00963.2015.

Metabolic Syndrome and Cerebral Vascular Function

Riddle me this: if you were going to be stuck on an island with only one drug, which drug offers “the best bang for your buck” in controlling metabolic syndrome due to obesity? That’s just one question we tackle in this podcast about the translational work by Brooks et al on how metabolic syndrome in obesity affects the cerebral microvasculature, published as part of our Call for Papers on Small Vessels – Big Problems. Guest Editor Akos Koller (New York Medical College and University of Physical Education, Budapest, Hungary) interviews lead author Paul Chantler (West Virginia University) and content expert Julian Lombard (Medical College of Wisconsin) about the adaptions in cerebral circulation during the progression of metabolic syndrome using an obese Zucker rat model of human disease. How do pharmacological interventions aimed at treating major risk factors such as blood pressure and glucose levels affect cerebrovascular changes in metabolic syndrome? With metabolic syndrome affecting nearly 57 million adults in the U.S., you can’t afford not to listen to this engaging, insightful podcast.

Steven D. Brooks, Evan DeVallance, Alexandre C. d'Audiffret, Stephanie J. Frisbee, Lawrence E. Tabone, Carl D. Shrader, Jefferson C. Frisbee, Paul D. Chantler Metabolic syndrome impairs reactivity and wall mechanics of cerebral resistance arteries in obese Zucker rats Am J Physiol Heart Circ Physiol, published December 1, 2015, DOI: 10.1152/ajpheart.00691.2015.

Determinants of Intra-cardiac Kinetic Energy

What do we know about the kinetic energy of intra-cardiac blood flow during the two phases of the cardiac cycle? Virtually nothing. That’s what Steding-Ehrenborg et al seek to change in a new study we explore in this podcast. Listen as Associate Editor Fabio Recchia (Temple University Lewis Katz School of Medicine, and Scuola Superiore Sant'Anna, Pisa, Italy) interviews lead author Katarina Steding-Ehrenborg (Lund University) and content expert Martin Ugander (Karolinska University Hospital) about how the authors used state-of-the-art cardiac magnetic resonance imaging with 4-dimensional phase-contrast sequences to compare kinetic energy in atrial and ventricular chambers in both healthy volunteers and elite endurance athletes. What are the differences in the filling mechanisms between the two chambers of the heart, and how does this affect cardiac pump function? What does high, or low, intra-cardiac blood flow kinetic energy really mean? Listen as we unpack the details of this intriguing, ground-breaking new work.

Katarina Steding-Ehrenborg, Per Martin Arvidsson, Johannes Toger, Mattias Rydberg, Einar Heiberg, Marcus Carlsson, Hakan Arheden Determinants of kinetic energy of blood flow in the four-chambered heart in athletes and sedentary controls Am J Physiol Heart Circ Physiol, published January 1, 2016. DOI: 10.1152/ajpheart.00544.2015.

Roles of CSE and MPST in Coronary Vasoregulation

What role does hydrogen sulfide play in coronary vascular function? That’s just what lead author Lakshmi Santhanam and colleagues set out to uncover in the work by Kuo et al, which we discuss in this podcast. Associate Editor Nancy Kanagy (University of New Mexico School of Medicine) interviews Santhanam (Johns Hopkins University) and content expert Christopher Kevil (Louisiana State University) about the role and source of hydrogen sulfide in coronary arteries and the discovery that the endothelial enzyme 3-mercaptypyruvate sulfertransferase (MPST) is the primary regulator. Does MPST operate in other vascular beds? Are the fluorescence indicators used by Santhanam and co-authors a reliable tool to detect real-time measurements of hydrogen sulfide production? Listen and find out.

Maggie M. Kuo, Dae Hee Kim, Sandeep Jandu, Yehudit Bergman, Siqi Tan, Huilei Wang, Deepesh R. Pandey, Theodore P. Abraham, Artin A. Shoukas, Dan E. Berkowitz, Lakshmi Santhanam MPST but not CSE is the primary regulator of hydrogen sulfide production and function in the coronary artery Am J Physiol Heart Circ Physiol, published January 1, 2016. DOI: 10.1152/ajpheart.00574.2014.

Radiation-Induced Regulatory Networks in Cardiomyocytes

What do deep space travel and AJP-Heart and Circ have in common? This podcast. Listen as Associate Editor Leon De Windt interviews lead author David Goukassian (Boston University School of Medicine) and content expert Martin E. Young (University of Alabama at Birmingham) about the intriguing new study by Coleman et al. Goukassian and his team studied the effects of low dose, full body, low energy radiation on heart physiology. This type of radiation is relevant for radiotherapy and for future deep space travel by astronauts when mankind starts exploring our galaxy. At a dose of 0.15 Grey iron particles, cardiomyocytes demonstrated long-lived changes in gene expression consistent with inflammatory and free radical scavenging gene ontologies. We discussed how space travel could disrupt our circadian rhythm, our natural 24 hour day/night cycle. In addition, this study give clues as to which regions of deep space we should avoid in order to protect our circadian rhythm. Finally, we speculated about the existence of radiation-specific diagnostic markers, and how anti-inflammatory agents may be used in the future for treatment of radiation-induced tissue damage. Listen-- it is fascinating.

Matthew A. Coleman, Sharath P. Sasi, Jillian Onufrak, Mohan Natarajan, Krishnan Manickam, John Schwab, Sujatha Muralidharan, Leif E. Peterson, Yuriy O. Alekseyev, Xinhua Yan, David A. Goukassian Low-dose radiation affects cardiac physiology: gene networks and molecular signaling in cardiomyocytes Am J Physiol Heart Circ Physiol, published December 1, 2015, DOI: 10.1152/ajpheart.00050.2015.